Search results for "Lucan"

showing 10 items of 161 documents

Secretion, interaction and assembly of two O-glycosylated cell wall antigens from Candida albicans.

2001

The mechanisms of incorporation of two antigens have been determined using a monoclonal antibody (3A10) raised against the material released from the mycelial cell wall by zymolyase digestion and retained on a concanavalin A column. One of the hybridomas secreted an IgG that reacted with two bands in Western blots. Indirect immunofluorescence showed that the antigens were located on the surfaces of mycelial cells, but within the cell walls of yeasts. These antigens were detected in a membrane preparation, in the SDS-soluble material and in the material released by a 1,3-beta-glucanase and chitinase from the cell walls of yeast and mycelial cells. In the latter three samples, an additional h…

Antigens FungalGlycosylationbeta-GlucansMicrobiologyCell wallEndoglycosidase Hchemistry.chemical_compoundMiceAntigenChitinCell WallCandida albicansAnimalsSecretionFluorescent Antibody Technique IndirectGlucansAntibodies FungalMice Inbred BALB CMembrane GlycoproteinsbiologyAntibodies MonoclonalMolecular biologyBiochemistrychemistryConcanavalin AChitinasebiology.proteinFemaleAntibodyMicrobiology (Reading, England)
researchProduct

Wall formation by Candida albicans yeast cells: synthesis, secretion and incorporation of two types of mannoproteins.

1993

SUMMARY: The mannoprotein components solubilized from the walls of Candida albicans blastoconidia following degradation of the glucan network with β-glucanase (Zymolyase) have higher molecular masses than their probable precursors present in the supernatant of regenerating protoplasts. It therefore appears that the mannoproteins are released from the walls as part of supramolecular complexes. Immunological analysis using both polyclonal and monoclonal antibodies has demonstrated the probable relationship between molecules found in a mixed membrane preparation, those secreted by regenerating protoplasts, and those present in yeast cell walls. Some mannoproteins secreted by protoplasts incuba…

Antigens FungalMicrobiologyCell wallFungal Proteinschemistry.chemical_compoundMiceCell WallCandida albicansAnimalsProtein PrecursorsCandida albicansMannanGlucanchemistry.chemical_classificationMembrane GlycoproteinsbiologyImmunochemistryProtoplastsTunicamycinAntibodies MonoclonalTunicamycinbiology.organism_classificationYeastcarbohydrates (lipids)chemistryBiochemistryConcanavalin APolyclonal antibodiesbiology.proteinJournal of general microbiology
researchProduct

Characterization of cell wall proteins from yeast and mycelial cells of Candida albicans by labelling with biotin: Comparison with other techniques

1992

Candida albicans ATCC 26555 blastoconidia and blastoconidia bearing germ tubes were metabolically labelled by incubating the cells with 14C-labelled protein hydrolysate and were subsequently tagged with biotin. Double-labelled (radioactive and biotinylated) cell wall proteins and glycoproteins were extracted from intact cells of both growth forms by treatment with 2-mercaptoethanol (beta ME) and with beta-glucanases (Zymolyase) after treatment with beta ME. The beta ME- and Zymolyase-extracts were separated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis and western blotted (immunoblotted) to nitrocellulose paper. Polyacrylamide gels were stained with Coomassie blue and process…

Antigens Fungalmedicine.drug_classImmunologyBlotting WesternBiotinBiologyMonoclonal antibodyMicrobiologyFungal ProteinsWestern blotCell WallCandida albicansmedicineGlycoproteinsMercaptoethanolGel electrophoresisFungal proteinmedicine.diagnostic_testStaining and LabelingGlucan Endo-13-beta-D-GlucosidaseMolecular biologyStainingBlotInfectious DiseasesBiochemistrySolubilityPolyclonal antibodiesBiotinylationAntigens Surfacebiology.proteinAutoradiographyParasitologyResearch Article
researchProduct

Sulphoevernan, a polyanionic polysaccharide, and the narcissus lectin potently inhibit human immunodeficiency virus infection by binding to viral env…

1990

Sulphoevernan is a sulphated alpha-1----3, 1----4 polyglucan (Mr 20,000) with a helical structure. This compound effectively inhibits both human immunodeficiency virus type 1 (HIV-1) and type 2 infection of cells in vitro at concentrations around 0.5 micrograms/ml. Moreover, the compound completely inhibits HIV-1-induced syncytium formation at a concentration of 1 microgram/ml. Competition experiments with 35S-labelled sulphoevernan revealed that the mannose-specific lectin from Narcissus pseudonarcissus prevented binding of sulphoevernan to HIV-1, whereas the antibody OKT4A did not reduce the amount of sulphoevernan bound to MT-2 cells. These data indicate that the non-cytotoxic polymer su…

Antiviral AgentsVirusCell LineViral envelopeViral Envelope ProteinsIn vivoPolysaccharidesVirologyLectinsMurine leukemia virusHumansGlucansSyncytiumbiologyLectinbiology.organism_classificationVirologyIn vitroHIV-2biology.proteinHIV-1AntibodyPlant LectinsZidovudineCell DivisionProtein BindingThe Journal of general virology
researchProduct

Comparison of Components Released by Fermented or Active Dried Yeasts after Aging on Lees in a Model Wine

2003

Comparison of different components released during autolysis with fermented or active dried yeast, which has never been reported previously, is related in this paper. Three autolysates were elaborated with Saccharomyces cerevisiae in a model wine (pH 3.5) at 30 or 18 degrees C. Composition of the autolysate appears to depend on both the growth medium and the physiological state of the yeast. The autolysate obtained from active dried yeast presents a higher total nitrogen concentration (a factor of 1.5-1.9 for the fermented yeast autolysate), a greater proportion of free amino acids (42 vs 16-25%), the lowest proportion of oligopeptides (25 vs 31-37%) and polypeptides (27 vs 45-34%), and an …

Autolysis (biology)NitrogenSaccharomyces cerevisiaeWineSaccharomyces cerevisiaeBiologyEthanol fermentationLeeschemistry.chemical_compoundFood scienceAmino AcidsGlucansWineGrowth mediumMembrane GlycoproteinsBacteriaHydrolysisMonosaccharidesProteinsNucleosidesGeneral Chemistrybiology.organism_classificationYeastBiochemistrychemistryFermentationFermentationPeptidesGeneral Agricultural and Biological SciencesOligopeptidesJournal of Agricultural and Food Chemistry
researchProduct

Safety, tolerability, pharmacokinetics, pharmacodynamics, and exploratory efficacy of the novel enzyme replacement therapy avalglucosidase alfa (neoG…

2019

This multicenter/multinational, open-label, ascending-dose study (NCT01898364) evaluated safety, tolerability, pharmacokinetics, pharmacodynamics, and exploratory efficacy of repeat-dose avalglucosidase alfa (neoGAA), a second-generation, recombinant acid α-glucosidase replacement therapy, in late-onset Pompe disease (LOPD). Patients ≥18 years, alglucosidase alfa naïve (Naïve) or previously receiving alglucosidase alfa for ≥9 months (Switch), with baseline FVC ≥50% predicted and independently ambulatory, received every-other-week avalglucosidase alfa 5, 10, or 20 mg/kg over 24 weeks. 9/10 Naïve and 12/14 Switch patients completed the study. Avalglucosidase alfa was well-tolerated; no deaths…

Avalglucosidase alfa (neoGAA)0301 basic medicineMaleGLUCOSE TETRASACCHARIDELysosomal acid alpha-glucosidase (GAA) deficiencyCHILDRENPulmonary function testingMOTOR FUNCTION0302 clinical medicineMedicineGenetics (clinical)Late-onset Pompe disease (LOPD)Glycogen Storage Disease Type IIAlglucosidase alfaMOUSE MODELEnzyme replacement therapyMiddle AgedTreatment OutcomeNeurologyTolerabilityEnzyme replacement therapySKELETAL-MUSCLEFemaleLife Sciences & BiomedicineMUSCLE TRAINING RMTGlycogen6-MINUTE WALKmedicine.drugAdultmedicine.medical_specialtyClinical NeurologyGLYCOGEN03 medical and health sciencesFEV1/FVC ratioPharmacokineticsInternal medicineHumansEnzyme Replacement TherapyAdverse effectAlglucosidase alfaScience & Technologybusiness.industryNeurosciencesalpha-GlucosidasesADULTSGlycogen storage disease type IISEVERITY030104 developmental biologyPharmacodynamicsPediatrics Perinatology and Child HealthNeurosciences & NeurologyNeurology (clinical)Glucan 14-alpha-Glucosidasebusiness030217 neurology & neurosurgeryNeuromuscular Disorders
researchProduct

Overexpression of a cell wall enzyme reduces xyloglucan depolymerization and softening of transgenic tomato fruits.

2010

Xyloglucan xyloglucosyltransferase/endohydrolase (XTHs: EC 2.4.1.207 and/or EC 3.2.1.151) has been proposed to have a dual role integrating newly secreted xyloglucan chains into an existing wall-bound xyloglucan and restructuring existing cell wall material by catalyzing transglucosylation between previously wall bound xyloglucan molecules. In this work we generated transgenic tomatoes with altered levels of an XTH gene. These transgenic fruits showed significant overexpression of the XTH proteins in comparison with the wild type. Specific XET activity was approximately 4.33 fold higher in the transgenic fruits compared with the wild type fruits, although in both cases the activity decrease…

Base SequenceDepolymerizationTransgeneWild typefood and beveragesRipeningGeneral ChemistryPlants Genetically ModifiedPolymerase Chain ReactionCell wallXyloglucanchemistry.chemical_compoundchemistryBiochemistrySolanum lycopersicumCell WallPolysaccharidesGenetically modified tomatoRNA MessengerGeneral Agricultural and Biological SciencesSofteningDNA PrimersJournal of agricultural and food chemistry
researchProduct

San Giorgio Lucano

2010

Basilicata San Giorgio LucanoSettore L-ANT/07 - Archeologia Classica
researchProduct

Guerra giusta e guerra ingiusta nella Pharsalia di Lucano

2010

Bellum iustum Lucano PharsaliaSettore L-FIL-LET/04 - Lingua E Letteratura Latina
researchProduct

Biocompatibility, hemocompatibility and antimicrobial properties of xyloglucan-based hydrogel film for wound healing application.

2018

Crosslinked xyloglucan-poly(vinyl alcohol) based hydrogel films are interesting materials for wound healing applications. This work focuses on the hydrolytic degradation and consequent morphological modification of a XG-PVA film and on its interaction with cells, blood, bacteria. Biocompatibility of the film was assessed in vitro by investigating different aspects, such as cell viability, oxidative stress level, mitochondrial dysfunction and specific stress biomarkers. Partial adhesiveness was demonstrated by performing different attaching assays and phalloidin staining. Hemocompatibility of XG-PVA film after interaction with blood was evaluated by using a multi-parametric approach, includi…

BiocompatibilityadhesivenessBiocompatible Materials02 engineering and technologyFibrinogenPeripheral blood mononuclear cellBiochemistryHemocompatibility03 medical and health sciencesThrombinAnti-Infective AgentsIn vivoStructural BiologymedicineHumansPlateletViability assayMolecular BiologyGlucans030304 developmental biology0303 health sciencesBacterial growthHemostasisWound Healingintegumentary systemChemistryHydrolysisGeneral Medicine021001 nanoscience & nanotechnologyMethylgalactosidesAdhesiveneMitochondriaOxidative StressA549 CellsBiophysicsBiocompatibilityXylansSettore CHIM/07 - Fondamenti Chimici Delle Tecnologie0210 nano-technologyWound healingmedicine.drugInternational journal of biological macromolecules
researchProduct